Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay™ picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes proprietary PicoWay technology to generate picosecond pulses for the treatment of pigmented lesions and tattoos, including recalcitrant tattoos. The staged launch of PicoWay begins in the international market during October 2014 and will continue in the United States in the first half of 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762556-syneron-launch-picoway-picosecond/
A majority of small and medium-sized businesses (SMBs) want better sustainability programs but are hindered by costs and a perception that investments in these initiatives don’t matter to customers, according to a sustainability survey released today by Cox Enterprises. The Cox Conserves Sustainability Survey is the first nationwide survey to examine sustainability opportunities and challenges for SMB leaders.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7285251-cox-conserves-sustainability-survey-smb/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, today celebrates its 25th birthday by releasing the first in a series of ‘made at CPhI’ pharma stories. These will follow 25 pharma industry successes that have directly resulted from meetings at CPhI. The first story charts Global Pharmaceutical Relief from a first meeting at CPhI only two years ago to today and providing hundreds of millions of dollars worth of medicines to the developing world via NGOs- not just another business story, but a great example of the CPhI family helping to proliferate healthcare throughout the globe.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762554-cphi-worldwide-celebrates-25-years/
For the first time ever, a new study conducted by Oxford Economics examines the broad economic impact the gaming industry as a whole has on the U.S. economy. The American Gaming Association released the first-of-its-kind study, which measures the economic impact of every facet of the casino gaming industry–commercial casinos and manufacturers and Native American casinos–as well as the industry’s significant ripple effect on the supply chain, including local businesses.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7338051-american-gaming-association-releases-oxford-economics-gaming-industry-impact-study/
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Today at the 10th Annual Meeting of the Clinton Global Initiative (CGI) in New York City, the Ad Council in partnership with Year Up, the Employment Pathways Project, ConPRmetidos, MENTOR: The National Mentoring Partnership, New Options Project, and Opportunity Nation launched the national “Grads of Life” campaign to help businesses fill more than 4 million vacant positions within the United States with qualified workers. The launch took place during CGI’s inaugural in-person meeting of the new Youth Employment Action Network attended by both business and non-profit leaders.
Secretary Hillary Clinton shared a message in support of the launch: “As we continue the work of Job One at The Clinton Foundation, we need to continue to build partnerships and to recruit more businesses to solve this important economic challenge. The Grads of Life PSA campaign is the first effort to drive employer demand for the millions of low-income young adults that are a huge source of untapped talent in our country and through GradsofLife.org employers can now access the first-ever online platform for the information, tools, and resources they need to take action today. I am asking employers, educators, non-profits, community leaders to join me and the Grads of Life campaign in this bold agenda to grow our economy and to create new opportunities for tomorrow’s leaders.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7328451-new-grads-of-life-campaign-launched-to-bridge-the-gap-between-employers-and-opportunity-youth/
ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the ACCU-CHEK® Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents a significant advancement in blood glucose meter technology for people with diabetes who take multiple daily insulin injections. The meter’s integrated bolus calculator provides easy-to-use and reliable dose recommendations based on automated calculations, eliminating the need for manual dosing calculations and estimations.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322751-roche-accu-chek-aviva-expert-blood-glucose-meter-now-available/
Sick of deeply personal accounts written in the first person? Seeking an exciting, interactive read that puts the “u” back in “aUtobiography”? Then look no further than Neil Patrick Harris: Choose Your Own Autobiography! In this revolutionary, Joycean experiment in light celebrity narrative, actor/personality/carbon-based-life-form Neil Patrick Harris lets you, the reader, live his life. NEIL PATRICK HARRIS
CHOOSE YOUR OWN AUTOBIOGRAPHY
www.nphbook.com Humor, entertainment, biography, memoir, comedy
The Global Standard for Digital Transaction Management™ (DTM) and the #1 rated eSignature app on iTunes, DocuSign today announced its enhanced mobile app that delivers the ability to quickly and easily sign documents on iOS 8 devices with the security of biometric authentication using Apple Touch ID. DocuSign’s mobile app is one of the first productivity apps to integrate new capabilities exclusive to Apple’s powerful new mobile operating system.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7312251-docusign-biometric-authentication-esignature-mobile-app-touch-id-ios-8/
Design and architecture fans now have the opportunity to tour the first-ever Real Simple and This Old House “2014 Dream Home of the Year”.
The luxury-quality, award-winning Breezehouse built by Blu® Homes, Inc. (“Blu”), America’s leading provider of premium prefab homes, is the epitome of a Southern California “Dream Home” and is packed with inspiration, resources and ideas to help visitors bring their own “dream home” to life. The L.A. Dream Home, which will be featured in the September issue of both Real Simple and This Old House magazines, is open to the public to tour the weekends of September 13-14; September 20-21; and September 27-28. Admission is free. More information, including how to use convenient shuttles to visit the house, can be found at www.bluhomes.com/designsmart.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7043256-blu-homes-breezehouse-awarded-2014-dream-home-of-the-year-by-real-simple-and-this-old-house/
Crimson Wine Group (CWG), today announced the national release of Luminary, the first American wine to cross state lines and blend fruit from four iconic properties in four renowned wine regions through a collaborative effort to create a truly unique wine. The first American wine of its kind, Luminary is an extension of the driving philosophy of the Crimson Wine Group and showcases the preeminent appellations and estate vineyard sites of each region with a dedication to handcrafted quality and the highest respect for the land. A bold new concept for the red wine category, Luminary represents a unique blend that only Crimson Wine Group can create from its preeminent estate holdings.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7310651-crimson-wine-group-launches-luminary-highly-anticipated-renowned-american/
